SCM
AGN.PRA

Sandler Capital Management’s Allergan plc AGN.PRA Stock Holding History

Sandler Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-600
Closed -$443K – 156
2017
Q3 		$443K Hold
600
– – 0.06% 103
2017
Q2 		$520K Hold
600
– – 0.06% 124
2017
Q1 		$509K Hold
600
– – 0.04% 163
2016
Q4 		$457K Sell
600
-900
-60% -$680K 0.04% 132
2016
Q3 		$1.23M Buy
1,500
+95
+7% +$82.1K 0.15% 83
2016
Q2 		$1.17M Buy
1,405
+330
+31% +$276K 0.15% 89
2016
Q1 		$988K Sell
1,075
-500
-32% -$478K 0.12% 97
2015
Q4 		$1.62M Sell
1,575
-125
-7% -$126K 0.15% 111
2015
Q3 		$1.6M Buy
1,700
+600
+55% +$626K 0.19% 107
2015
Q2 		$1.15M Buy
+1,100
New +$1.15M 0.1% 152

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Sandler Capital Management's AGN.PRA Position: Q4 2017 in Review

Sandler Capital Management sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 600 shares — an estimated $443K sold.

Sandler Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $1.62M in Q4 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Sandler Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Sandler Capital Management sold 600 Allergan plc shares in Q4 2017, an estimated $443K.
  • Sandler Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Sandler Capital Management's Allergan plc position peaked at $1.62M in Q4 2015.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Sandler Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.